Empire Financial Management Company’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$375K Hold
6,190
0.08% 172
2025
Q4
$334K Buy
6,190
+200
+3% +$9.62K 0.07% 177
2025
Q3
$270K Hold
5,990
0.06% 187
2025
Q2
$277K Buy
5,990
+50
+0.8% +$2.45K 0.08% 173
2025
Q1
$362K Hold
5,940
0.11% 161
2024
Q4
$336K Buy
+5,940
New +$332K 0.1% 164
2024
Q2
Sell
-11,940
Closed -$648K 201
2024
Q1
$648K Sell
11,940
-5,086
-30% -$259K 0.21% 123
2023
Q4
$874K Sell
17,026
-12,819
-43% -$673K 0.34% 79
2023
Q3
$1.73M Sell
29,845
-460
-2% -$28.2K 0.75% 42
2023
Q2
$1.94M Buy
30,305
+25,265
+501% +$1.69M 0.77% 42
2023
Q1
$349K Buy
+5,040
New +$355K 0.14% 150

Other funds holding BMY

Empire Financial Management Company's BMY Position: Q1 2026 in Review

Empire Financial Management Company held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 6,190 shares worth $375K. The position accounts for 0.08% of the portfolio, ranked #172.

Empire Financial Management Company first reported a position in BMY in Q1 2023 and has held it in 11 quarters since. The position peaked at $1.94M in Q2 2023. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Empire Financial Management Company held 6,190 shares of Bristol-Myers Squibb worth $375K as of Q1 2026.
  • Empire Financial Management Company left its Bristol-Myers Squibb share count unchanged in Q1 2026.
  • Bristol-Myers Squibb made up 0.08% of Empire Financial Management Company's portfolio in Q1 2026, its #172 holding.
  • Empire Financial Management Company first reported a position in Bristol-Myers Squibb in Q1 2023 and has held it in 11 quarters since.
  • Empire Financial Management Company's Bristol-Myers Squibb position peaked at $1.94M in Q2 2023.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Empire Financial Management Company's 13F filing for Q1 2026, filed 18 May 2026.